Jos Malda highlights the significant value of the newly established Innovation Center for Advanced Therapies (ICAT) for the prevention and control of diseases. The ICAT aims to fast-track the availability of personalised regenerative treatments. These treatments are partly developed on the basis of immune cell, stem cell and organoid technology, in which Utrecht plays a pioneering role. The ICAT is a joint initiative of the Hubrecht Institute, the Princess Máxima Center, the University Medical Center Utrecht UMCU and Utrecht University.